Status:
ENROLLING_BY_INVITATION
Cleidocranial Dysplasia (CCD): From Genotype to Phenotype and Considerations for Care
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Greenberg Center
Conditions:
Cleidocranial Dysostosis
Eligibility:
All Genders
Brief Summary
Cleidocranial Dysplasia (CCD) is a rare, autosomal dominant disorder characterized by dysplasia of bones and teeth. Given the rarity of this condition (prevalence of 1 in 1,000,000), the variable phen...
Eligibility Criteria
Inclusion
- Patient has molecular or clinical diagnosis of CCD
- Caregiver or parent of patient with CCD.
Exclusion
- Patient does not have CCD
- Patient over 18 but cannot consent for themselves
- Not fluent in English.
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05368064
Start Date
October 1 2021
End Date
December 31 2028
Last Update
October 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21205